Appendix table: Comparison of ADAMTS13 assays in plasma and serum
Patient . | Immunoblotting assay (% activity) . | FRETS-VWF73 assay (% activity) . | ||
---|---|---|---|---|
Plasma . | Serum . | Plasma . | Serum . | |
A | < 5 | < 5 | < 5 | < 5 |
B | 60 | 70 | 92 | 105 |
C | 30 | 30 | 62 | 74 |
D | < 5 | < 5 | < 5 | < 5 |
E | < 5 | < 5 | < 5 | < 5 |
F | 42.5 | 50 | 54 | 59 |
G | 60 | 60 | 55 | 60 |
H | 85 | 80 | 95 | 115 |
I | < 5 | 7 | < 5 | < 5 |
J | 60 | 75 | 58 | 66 |
K | 10 | 7 | 7 | 9 |
L | 60 | 70 | 91 | 97 |
M | 27.5 | 35 | 33 | 31 |
Patient . | Immunoblotting assay (% activity) . | FRETS-VWF73 assay (% activity) . | ||
---|---|---|---|---|
Plasma . | Serum . | Plasma . | Serum . | |
A | < 5 | < 5 | < 5 | < 5 |
B | 60 | 70 | 92 | 105 |
C | 30 | 30 | 62 | 74 |
D | < 5 | < 5 | < 5 | < 5 |
E | < 5 | < 5 | < 5 | < 5 |
F | 42.5 | 50 | 54 | 59 |
G | 60 | 60 | 55 | 60 |
H | 85 | 80 | 95 | 115 |
I | < 5 | 7 | < 5 | < 5 |
J | 60 | 75 | 58 | 66 |
K | 10 | 7 | 7 | 9 |
L | 60 | 70 | 91 | 97 |
M | 27.5 | 35 | 33 | 31 |